Can AI replace medical writers? Experts say not immediately
Artificial intelligence (AI) is said to be exponentially faster and effective at writing lengthy and complex clinical trial documents, but…
Artificial intelligence (AI) is said to be exponentially faster and effective at writing lengthy and complex clinical trial documents, but…
The UK pharma industry can expect resolutions on a range of issues, including VPAG [Voluntary Scheme for Branded Medicines Pricing…
Leaders of the Association of the British Pharmaceutical Industry (ABPI) say the UK Government must address rising clawback rates on…
As a funding drought for biopharma is on the horizon, non-profit biotech Orphan Therapeutics Accelerator is championing an innovative funding…
As cell and gene therapy developers struggle against an investment slump and competition from established autologous treatments, allogeneic cell therapies…
The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial…
In step with international news in recent times, European pharma and biotech are leaning towards ‘nearshoring’, preferring domestic operations to…
Widespread integration of machine learning (ML) into supply chain management by major pharma suppliers is just a few years away,…
A major overhaul and consolidation of EU clinical trial regulations is paving the way to faster approvals, greater international coordination,…
Earlier this month, the newly empowered role of the European Union (EU)’s Executive Steering Group on Shortages and Safety of…